By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pepiniere Sante Cochin
29 rue du Faubourg Saint Jacques
Paris    75014  France
Phone: 01-55-426200 Fax: 01-55-426201


Company News
PHARNEXT To Present At 2017 BIO CEO & Investor Conference 2/7/2017 7:13:38 AM
PHARNEXT Announces Findings Evaluating Charcot-Marie-Tooth Neuropathy Score 2/2/2017 6:29:56 AM
PHARNEXT To Attend January Investor Conferences 1/4/2017 8:46:32 AM
PHARNEXT Completes Patient Enrollment In International Pivotal Phase 3 Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 12/20/2016 12:58:14 PM
PHARNEXT Presents Positive Exploratory Phase 2 Data From PXT864 At The 9th Clinical Trials On Alzheimer’s Disease (CTAD) Conference In San Diego, United States 12/13/2016 11:20:45 AM
PHARNEXT Announces That The Data Safety Monitoring Boardrecommends Continuing The Ongoing Phase 3 Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 11/17/2016 11:35:26 AM
PHARNEXT Announces Support Of The First Patient-Centered Charcot-Marie-Tooth Summit Organized By The Hereditary Neuropathy Foundation 10/4/2016 12:30:46 PM
PHARNEXT Confirms Its Continuous Support Of The Hereditary Neuropathy Foundation To Increase Global Awareness Of Charcot-Marie-Tooth Disease 9/15/2016 11:39:01 AM
PHARNEXT’s PXT3003 Featured In Multiple Presentations At The 6th International Charcot-Marie-Tooth And Related Neuropathy Consortium (CMTR) Meeting 9/1/2016 11:25:56 AM
PHARNEXT Announces The Appointment Of René Goedkoop As Chief Medical Officer And François Chamoun As General Counsel 7/26/2016 11:03:22 AM